Abstract. Recurrence and metastasis are the main obstacles to improving the survival of patients with post-resective hepatocellular carcinoma (HCC). Our previous study suggests a critical role of CXCR7 in the metastasis of HCC. In the present study, the effect of CXCR7 as a risk factor for metastasis of HCC was evaluated. Immunohistochemical assay was performed on tissue microarrays based on HCC with extrahepatic metastases after hepatectomy. Two categories based on staining scores were used to evaluate the risk effect of CXCR7, respectively. The effect of CXCR7 on osteopontin (OPN) was explored by RNA interference. Based on the results, in both categories, highly expressed CXCR7 was a dependent risk factor for extrahepatic metastasis because of the potential association with relatively good cell differentiation. Stratification analyses indicated that CXCR7 was a strong independent risk factor (OR, 3.40; 95% CI, 1.07-18.84; P=0.038 in category 1 and OR, 6.40; 95% CI, 1.64-24.92; P=0.007 in category 2, respectively) in patients with Edmondson grade 1/2. Furthermore, CXCR7 correlated well and positively with expression of OPN (P=0.019 and P<0.001 in two categories, respectively) in HCC cases with Edmondson grade 1/2. Immunocytochemistry and RT-PCR demonstrated downregulation of OPN in a highly metastatic HCC cell line following knockdown of CXCR7. Taken together, these findings suggest that high expression of CXCR7 increases the risk of metastasis in post-resective HCC patients with relatively good differentiated tumors, potentially through upregulation of OPN. This group of patients may acquire a survival benefit from early detection and treatment of recurrence and metastasis.
Introduction
Recurrence and metastasis are still the main obstacles to improving the survival of patients with hepatocellular carcinoma (1, 2) and are associated with highly increased morbidity and mortality worldwide. Several risk factors including tumor size, microvessel invasion and poor differentiation, have been demonstrated to increase the risk of recurrence and even extrahepatic metastasis of post-resective HCC patients (1) and their identification can aid in carrying out more positive treatment strategies, such as adjuvant TACE. However, the heterogeneity and molecular biological characteristics of HCC increase the complexity and difficulties of therapy. Providing treatment according to the differential characteristics of specific subgroups of HCC may decrease the potential of recurrence and metastasis, and this is becoming the future developmental trend in treatment strategy.
Chemokine receptor CXCR7, belonging to one of the G-protein coupled seven-transmembrane receptors, has the definitive ligand stromal cell-derived factor-1α (SDF-1α) and truncated ITAC (CXCL11) (3, 4) . Accumulated research has shown chemokine receptors to be pertinent to the progression of tumors (5) . The level of CXCR7 expression has been demonstrated to be closely related to the invasive activities of prostate cancer cells (6) . In addition, higher expression of CXCR7 is linked to the early and metastatic recurrence in pathological stage I non-small cell lung cancer (7) . Recently, overexpression of CXCR7 was found in the HCC cell line SMMC-7721 and tumor tissues (8) . Moreover, CXCR7 can also be expressed by endothelial cells (9) . Our previous research showed that downregulation of CXCR7 inhibited the metastasis of HCC (10) . However, the potential merit of CXCR7 as a risk factor for extrahepatic metastasis is unclear.
In the present study, we evaluated the predictive role of CXCR7 as a risk factor in metastasis of post-resective human HCC. According to the immunohistochemical staining of the tissue microarray, high expression of CXCR7 increased the risk of extrahepatic metastasis prominently as an independent risk factor based on cell differentiation. Furthermore, the close relationship between CXCR7 and osteopontin (OPN) was found and was confirmed by immunocytochemistry and RT-PCR analysis of OPN after downregulation of CXCR7 in a highly metastatic HCC cell line by RNA interference (RNAi).
Materials and methods
Cell line. The highly metastatic human HCC cell line HCCLM-3 (100% lung metastatic potential) was used, which was established at the Liver Cancer Institute of Fudan University (Shanghai, China). The cell line was cultured in high glucose DMEM (Gibco-BRL, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (HyClone Laboratories, Inc., Logan, UT, USA).
Patients. One hundred and sixteen patients were retrieved from the prospectively designed database. TMA and immunohistochemistry. Hematoxylin and eosinstained slides were screened for optimal tumor content and tissue adjacent to tumor (TAT) with a distance of 2 cm. The TMA was then constructed in accordance with standard procedures (12) based on 116 tumor tissues and 47 TATs. Two cores were taken from each formalin-fixed, paraffin-embedded HCC samples by using punch cores that measured 1.0 mm in diameter from the center of tumor foci and TAT. A two-step method of immunohistochemistry including heat-induced antigen-retrieval procedure was performed in a standard manner. Rabbit anti-human CXCR7 IgG (Novus Biologicals, Littleton, CO, USA) at 1:200 and rabbit anti-human osteopontin IgG (Santa Cruz Biotechnology, Santa Cruz, CA, USA) at 1:200 were used as primary antibodies for detection. Detection without the primary antibody was considered as the negative control.
Scoring and categories of CXCR7 expression. The immunoassay was defined by the staining intensity and the percentage of positive tumor cells as previously described (13 RNAi. Small interference RNA (siRNA) transfection of HCCLM3 cells was performed according to the Lipofectamine 2000 protocol (14) . After 24 h, immunocytochemistry assay was performed as previously described (15) except that 1:800 rabbit anti-human OPN IgG (Millipore Corp., Billerica, MA, USA) was used as the primary antibody. RT-PCR was also used to determine the mRNA level of OPN: sense, 5'-GGACTCCATTGACTCGAACG-3'; antisense, 5'-TAA TCTGGACTGCTTGTGGC-3'.
Statistical analysis.
Pearson's Chi-square test was used to compare qualitative variables in the univariate analysis. When expected sample values were <5, Fisher's exact test was used. Twelve potential risk factors including CXCR7 for development of lung metastasis of HCC were all categorized variables. These included 4 clinical factors [age ≤60 years or >60 years; gender, HBsAg status and serum AFP level ≤20 µg/l or >20 µg/l (16)], and 8 pathological factors (cirrhosis or non-cirrhosis, tumor size ≤5 cm or >5 cm, single or multiple tumor nodules, well or poorly encapsulated tumor, the presence or absence of microvascular invasion, portal lymphatic status, Edmondson grade 1/2 [well-and moderately differentiated grades) or grade 3/4 (poorly differentiated grade) and CXCR7 staining]. Potential risk factors were selected from univariate analysis when P<0.25. Binary logistic regression was used as multivariate analysis to evaluate the screened risk factors. Receiver operation curve (ROC) was used further to confirm the predictive accuracy of the risk factors. Spearman's rank test was used to detect the correlation between CXCR7 and OPN. One-way ANOVA was used for intergroup comparisons. All P-values were 2-tailed and the statistical significance was set at 0.05. Statistical analyses were carried out using SPSS 18.0 software (SPSS Inc., Chicago, IL, USA).
Results
Association between high expression of CXCR7 and extrahepatic metastasis. The immunopositivity for CXCR7 was mainly observed in the membrane and cytoplasm of HCC cells. Typically, the stained HCC cells were mostly round or oval with increased karyoplasm ratio (Fig. 1) . Differential staining intensity of CXCR7 expression from negative to strong was observed in 20, 45 and 51 patients, respectively (Fig. 1) .
In category 1, 51.7% cases showed CXCR7 high in the patients with lung metastasis (n=58), whereas in the patients without lung metastasis (n=58), only 36.2% cases showed CXCR7 high . Immunopositivity for CXCR7 in patients with lung metastasis was potentially stronger than that in patients without metastasis [hazards ratio (HR), 1.89; 95% confidence interval (CI), 0.90-3.97; P=0.092]. Furthermore, in category 2, patients with lung metastasis showed significantly strong CXCR7 staining (HR, 2.59; 95% CI, 1.13-5.92; P=0.023).
In TAT analysis, no statistical difference was noted between patients with lung metastasis (n=23) and those without metastasis (n=24) for CXCR7 staining (P=0.302 in category 1). Furthermore, among 23 TATs of HCC with lung metastasis, only microvascular invasion was found to be associated with CXCR7 staining in category 1. Tumor cells with high expression of CXCR7 in TATs of patients exhibited stronger microvascular invasion (HR, 10.67; 95% CI, 1.04-109.94; P=0.027). Fig. 2A) In addition, we also analyzed the potential risk factors in 43 patients with poorly differentiated tumors (Edmondson grade 3/4). Univariate analysis showed that no potential risk factor was associated with lung metastasis except for microvascular invasion (P=0.065).
Role of CXCR7 in the increased
In category 2, stratification analysis of cell differentiation, or Edmondson grade 1/2 (n=62) further confirmed the risk predictive role of CXCR7 in category 1. In univariate analysis, 6 factors including CXCR7 staining (P=0.002) were potential risk factors (Table Ⅰ) . Multivariate analysis showed that CXCR7 staining (OR, 6.40; 95% CI, 1.64-24.92; P=0.007) and AFP (OR, 9.32; 95% CI, 1.76-49.36; P=0.009) were 2 independent risk factors for lung metastasis of patients with Edmondson grade 1/2. Patients with CXCR7 high had a 6.4-fold higher risk of developing lung metastasis than patients with CXCR7 low based on the differentiation of the tumor cells. In the ROC analysis, both factors accurately predicted the occurrence of lung metastasis, with AUC of 0.698 (95% CI, 0.565-0.832; P=0.009) for CXCR7 staining and AUC of 0.688 (95% CI, 0.555-0.820; P=0.013) for AFP (Fig. 2B) . 
Risk predictive role of CXCR7 is related to OPN expression.
Since OPN has been generally accepted as a factor closely related to the metastasis of HCC (17,18), we explored the potential association between the expression of CXCR7 and OPN. In this analysis, expression of OPN was divided into two groups: OPN high and OPN low . Following stratification of category 1 based on cell differentiation (Edmondson grade 1/2) (n=73), CXCR7 correlated well and positively with expression of OPN (Spearman's ρ= 0.240; P= 0.019). Furthermore, stratification analysis of category 2 (n=62) confirmed the positive and high correlation between CXCR7 and OPN (Spearman's ρ=0.453; P<0.001). There was a significantly statistical difference between CXCR7 and OPN expression (Fisher's exact test, P=0.000). In addition, analyses based on immunostaining indicated that the distribution and strength of CXCR7 were consistently and closely associated with OPN in HCCs with well or moderate differentiation (Fig. 3A) .
To confirm the potential regulatory role of CXCR7 in the expression of OPN, we detected the change in expression of OPN following downregulation of expression of CXCR7 in a highly metastatic HCC cell line. Both immunocytochemistry and RT-PCR found decreased expression of OPN following RNAi of CXCR7 (Fig. 3B) .
Discussion
In the present study, we found that high expression of CXCR7 increased the risk of metastasis in HCC patients receiving hepatectomy, particularly when tumor cells were well and moderately differentiated. Stratification analysis based on Edmondson grade 1/2 indicated that high expression of CXCR7 was a strong independent risk factor for metastasis. ROC analysis justified the predictive role of CXCR7. The results of category 2 further confirmed the results of category 1. These findings indicated that CXCR7 was a valuable risk factor for predicting metastasis in patients with relatively well-differentiated HCC. Moreover, accumulation of chromosomal changes has been found to be associated with metastatic behavior, and that LOH on 16q is a useful prognostic indicator for metastasis after curative resection of HCC (19) . In addition, HBsAg was shown to have a predictive role in extrahepatic metastasis after hepatic resection in patients with large hepatocellular carcinoma (20) .
Generally, poor differentiation indicates a more invasive character of tumor cells. In the present study, however, more than half of the patients (73/116) had well or moderate differentiation, and lung metastasis occurred in 30 patients in this group. Although well differentiation is generally associated with a favorable prognosis, pathological factors such as CXCR7 were still used to stratify patients with respect to lung metastasis after resection in this study. Based on CXCR7 expression, we may recognize and distinguish the patients prone to lung metastasis from patients with relatively welldifferentiated HCC and intervene in advance. Therefore, this group of patients may acquire survival benefits.
Why does high expression of CXCR7 have a strong predictive role for lung metastasis in patients with relative well-differentiated HCC but not in patients with poor-differentiated HCC? One of the potential reasons is the heterogeneity of HCC (21, 22) . Similarly to our study, previous research has shown that although early HCC is generally associated with a favorable prognosis, pathologic factors can still be used to stratify patients with respect to survival after resection (23) . In addition, histological heterogeneity was found in small but established HCC, which was accompanied by increased proliferative activity and p53 protein overexpression. The expression of β-catenin protein also has heterogeneous distribution, even in the same histological grade region of the same tumor (24) . Therefore, some HCC cells may acquire a new differentiation character such as high expression of CXCR7, which promotes the directional chemotaxis and metastasis of tumor cells to lung. On the other hand, apart from stimulating metastasis, research suggests other functions for CXCR7 such as its involvement in differentiation and development (25, 26) . In poorly differentiated tumors, an embryonic stem cell-like gene expression signature suggests that CXCR7 is epigenetically controlled by SUZ12.
In the present study, we also found an association between CXCR7 and OPN in stratification analyses based on cell differentiation, which may be pertinent to the increased risk of extrahepatic metastasis. Furthermore, in this study, knockdown of CXCR7 in a highly metastatic HCC cell line induced the downregulation of OPN which was demonstrated by immunocytochemistry and mRNA detection. Our findings are similar to research on the role of CXCR7 in the early development of osteoarthritis, which found that overexpression of CXCR7 upregulated the expression of OPN 9-fold (27) . Recent research has shown that CXCR7 participates in the non-classic pathway by activating mitogen-activated protein kinases through β-arrestin, (28) which may cross-talk with the Wnt signaling pathway. It is well known that OPN is the usual target of Wnt signaling in tumor progression (29, 30) . The activated transmembrane CXCR7 may cross-talk with Wnt signaling through β-arrestin, and upregulate the expression of OPN, which further stimulates the metastatic ability of tumor cells. However, the exact mechanism deserves future investigation.
In conclusion, high expression of CXCR7 increases the risk of post-operative metastasis in patients with relatively well-differentiated HCC. The potential for early occurence of lung metastasis can be predicted in advance based on CXCR7 detection. This group of patients may acquire a survival benefit from the early detection and prevention of lung metastasis.
